MSF: Johnson & Johnson deal falls short for people with tuberculosis
NEW YORK, JULY 13, 2023—Stop TB Partnership’s Global Drug Facility announcement today of a deal with US pharmaceutical corporation Johnson & Johnson (J&J) to provide access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline will only offer a short-term so